Ifg Advisory, LLC Ionis Pharmaceuticals Inc Transaction History

Ifg Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$59.06 - $72.15 $240,551 - $293,866	-4,073 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$62.09 - $86.14 $3,601 - $4,996	58 Added 1.44%	4,073 $261,000
Q1 2019 May 08, 2019	SELL	$52.92 - $81.17 $19,792 - $30,357	-374 Reduced 8.52%	4,015 $325,000
Q4 2018 Feb 07, 2019	BUY	$43.37 - $59.54 $910 - $1,250	21 Added 0.48%	4,389 $237,000
Q3 2018 Nov 05, 2018	BUY	$42.88 - $53.7 $187,299 - $234,561	4,368 New	4,368 $225,000
Q2 2018 Aug 02, 2018	SELL	$40.53 - $50.7 $199,407 - $249,444	-4,920 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$44.08 - $55.05 $2,204 - $2,752	-50 Reduced 1.01%	4,920 $0
Q4 2017 Feb 01, 2018	SELL	$50.3 - $64.39 $162,569 - $208,108	-3,232 Reduced 39.41%	4,970 $249,000
Q4 2017 Jan 29, 2018	BUY	$50.3 - $64.39 $412,560 - $528,126	8,202	8,202 $256,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.